Glimepiride and Pegasys drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Glimepiride (glimepiride) and Pegasys (peginterferon alfa 2a). Common drug interactions include pain of skin among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Glimepiride and Pegasys. It is created by eHealthMe based on reports of 73 people who take the same drugs from the FDA, and is updated regularly.

What is Glimepiride?

Glimepiride has active ingredients of glimepiride. It is often used in diabetes. eHealthMe is studying from 45,909 Glimepiride users. Check the latest studies of Glimepiride.

What is Pegasys?

Pegasys has active ingredients of peginterferon alfa 2a. It is often used in hepatitis c. eHealthMe is studying from 57,446 Pegasys users. Check the latest studies of Pegasys.

On Jul, 31, 2026

73 people who take Glimepiride and Pegasys together, and have interactions are studied.

Glimepiride and Pegasys drug interactions.

What are the common drug interactions of Glimepiride and Pegasys, by gender? *:

female:

Pain of skin
Pancreatitis (inflammation of pancreas)
Pneumonia
Swelling
Tremor (trembling or shaking movements in one or more parts of your body)
Weight increased
Rash
Dizziness
Memory impairment
Muscle spasms (muscle contraction)

male:

Anaemia (lack of blood)
Platelet count decreased
Arthralgia (joint pain)
Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
Decreased appetite
Dry eye (lack of adequate tears)
Dysgeusia (disorder of the sense of taste)
Dyspepsia (indigestion)
Fall
Helicobacter infection (helicobacter pylori (h. pylori) infects stomach)

What are the common drug interactions of Glimepiride and Pegasys, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Pyrexia (fever)
Vomiting
Cholangiocarcinoma (a cancer that forms glands or secretes significant amounts of mucins)
Hepatocellular carcinoma (liver cancer)
Pain
Injection site erythema (redness at injection site)
Injection site warmth
Nausea (feeling of having an urge to vomit)

50-59:

Diarrhoea
Dizziness
Headache (pain in head)
Pruritus (severe itching of the skin)
Abdominal pain upper
Aphthous stomatitis (mouth ulcer)
Appetite disorder (abnormal eating habits)
Arthralgia (joint pain)
Death
Drug ineffective

60+:

Anaemia (lack of blood)
Nausea (feeling of having an urge to vomit)
Dry eye (lack of adequate tears)
Fall
Helicobacter infection (helicobacter pylori (h. pylori) infects stomach)
Skin discolouration (change of skin colour)
Fatigue (feeling of tiredness)
Leukopenia (less number of white blood cells in blood)
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Pruritus (severe itching of the skin)

What are the existing conditions these people have? *

High Blood Pressure: 12 people, 16.44%
Type 2 Diabetes: 8 people, 10.96%
Pain: 6 people, 8.22%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 8.22%
Portal Hypertension (increase in the blood pressure within a system of veins called the portal venous system): 5 people, 6.85%
Headache (pain in head): 4 people, 5.48%
Diarrhea: 4 people, 5.48%
Chest Pain: 4 people, 5.48%
Back Pain: 4 people, 5.48%

* Approximation only. Some reports may have incomplete information.

Do you take Glimepiride and Pegasys?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously